Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months

BACKGROUND: PERTINENT is an active hospital-based surveillance system for pertussis in infants. In 2019, four of the six participating European countries recommended pertussis vaccination in pregnancy. Among infants aged <2 months, we measured the vaccine effectiveness (VE) in pregnancy; among in...

Descripción completa

Detalles Bibliográficos
Autores principales: Merdrignac, Lore, Acosta, Lesly, Habington, Adele, Garcìa Cenoz, Manuel, Pandolfi, Elisabetta, Fabiánová, Kateřina, Jordan, Iolanda, O'Sullivan, Niam, Navasués, Ana, Tozzi, Alberto E., Zavadilová, Jana, Jané, Mireia, Cotter, Suzanne, Pitillas, Nerea I., Rizzo, Caterina, Křížová, Pavla, Hanslik, Thomas, Muñoz Almagro, Carmen, Pastore, Lucia, Bacci, Sabrina, Moren, Alain, Valenciano, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589240/
https://www.ncbi.nlm.nih.gov/pubmed/36182617
http://dx.doi.org/10.1016/j.vaccine.2022.09.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589240/
https://www.ncbi.nlm.nih.gov/pubmed/36182617
http://dx.doi.org/10.1016/j.vaccine.2022.09.054

Ejemplares similares